This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 4 EPO patents. Top assignees: Chiralix B.v., Stichting Katholieke Universiteit, Academisch Ziekenhuis Leiden (h.o.d.n. Lumc). Active years: 2013-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Nijmeghen, NL (2013)
- The Netherlands, NL (2018)
- Nijmegen, NL (2016 - 2019)
Company Filing History:
2 out of 2 
2 out of 64 
1 out of 43 
Years Active: 2013-2019
Title: Richard Hendrik Blaauw: Innovator in Chemiluminescence-Based Assays
Introduction
Richard Hendrik Blaauw is a notable inventor based in Nijmegen, Netherlands. He has made significant contributions to the field of biochemistry, particularly in the development of innovative assays for blood clotting factors. With a total of four patents to his name, Blaauw's work has the potential to enhance diagnostic methods in medical laboratories.
Latest Patents
Among his latest patents is the "Chemiluminescence-based haemostasis assay." This invention relates to a method for in vitro determining the generation of haemostasis factors such as thrombin and plasmin in a test sample. The method utilizes a chemiluminescent substrate specific for these blood clotting factors. Upon cleavage of the substrate, a luminescent signal is generated with the aid of a luciferase. Additionally, the invention includes a kit for in vitro determining the generation of a haemostasis factor in a test sample, along with novel chemiluminescent substrates for the determination of thrombin and plasmin.
Career Highlights
Richard Hendrik Blaauw has worked with prominent organizations such as Stichting Katholieke Universiteit and Chiralix B.V. His experience in these institutions has allowed him to refine his skills and contribute to groundbreaking research in his field.
Collaborations
Blaauw has collaborated with notable colleagues, including Waander Laurens Van Heerde and Ruben Gerardus George Leenders. These partnerships have likely facilitated the exchange of ideas and fostered innovation in their respective projects.
Conclusion
Richard Hendrik Blaauw is a distinguished inventor whose work in chemiluminescence-based assays has the potential to revolutionize diagnostic practices. His contributions to the field are significant and reflect his dedication to advancing medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile